ArticlePloS one2022
Increasing incidence of reported scabies infestations in the Netherlands, 2011-2021.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial.BMJ (Clinical research ed.) · 2026Trial
- Temporal trends in scabies-related emergency department visits: a retrospective trend analysis of 10,994 visits.Annals of medicine · 2026Article
- The rising burden of scabies in Italy: insights from a nationwide survey of dermatologists.Tropical medicine and health · 2026Article
- Massive scabies outbreak in Rohingya refugee camps, Cox's Bazar: Epidemiology and impact of a mass drug administration (MDA) campaign - A retrospective study.PLoS neglected tropical diseases · 2026Observational
- Scabies among Dutch higher education students: do cases notify their contacts and do contacts take adequate measures?Parasites & vectors · 2026Article
- Including patient experiences from online sources in guidelines: A natural language processing study on scabies.PloS one · 2026Article
- Clinical presentation of scabies from 1996 to 2022: a retrospective cohort study from Finland.Scandinavian journal of primary health care · 2025Article
- Rising scabies incidence and the growing burden on GPs: a retrospective longitudinal study.BJGP open · 2025Article
- Estimation of the epidemiological characteristics of scabies.Nature communications · 2025Review
- Changes inThe Journal of international medical research · 2025Article
- Rising scabies incidence in Spain: a retrospective observational analysis of four national data sources, 2011 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Observational
- Treatment Failure in Scabies: Assessment of Risk Factors in a Multicenter Cross-Sectional Study.Dermatology practical & conceptual · 2025Article
- Socio-psychological determinants of scabies contact notification among Dutch students: A qualitative study.PLoS neglected tropical diseases · 2025Article
- Increasing trend of scabies in Belgium, 2000-2023.Archives of public health = Archives belges de sante publique · 2025Article
- [Epidemiological characteristics of patients with scabies at a Korean university hospital: a single-center retrospective study].Journal of Korean biological nursing science · 2025Article
- Antioxidant Potential of Medicinal Plants in the Treatment of Scabies Infestation.Molecules (Basel, Switzerland) · 2024Review
- Resurgence of scabies in Italy: The new life of an old disease.Parasite epidemiology and control · 2024Article
- Exploring transmission dynamics of the Sarcoptes scabiei mite in humans by combining molecular typing and epidemiological variables, the Netherlands 2016-2023.Parasites & vectors · 2024Article
- Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions.Journal of clinical medicine · 2024Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSeveral Public Health Services and general practitioners in the Netherlands observed an increase in scabies in the Netherlands. Since individual cases of scabies are not notifiable in the Netherlands, the epidemiological situation is mostly unknown. To investigate the scabies incidence in the Netherlands, we described the epidemiology of scabies between 2011 and 2021.
methodsTwo national data sources were analysed descriptively. One data source obtained incidence data of scabies (per 1,000 persons) of persons consulting in primary care from 2011-2020. The other data source captured the number of prescribed scabicides in the Netherlands from 2011-2021. To describe the correlation between the incidence of diagnoses and the number of dispensations between 2011 and 2020, we calculated a correlation coefficient.
resultsThe incidence of reported scabies has increased by more than threefold the last decade (2011-2020), mainly affecting adolescents and (young) adults. This was also clearly reflected in the fivefold increase in dispensations of scabicide medication during 2011-2021. The incidence and dispensations were at an all-time high in 2021. We found a strong correlation between the reported incidence and the number of dispensations between 2011 and 2020.
conclusionsMore awareness on early diagnosis, proper treatment and treatment of close contacts is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.